CASP3 and cancer: For instance, interrogation of the TCGA database demonstrated that GSDME had a high prevalence of mutations, which were especially concentrated around the caspase-3 cleavage site; 20 of 22 cancer-associated GSDME mutations tested were shown to inhibit its function (81).